New heart mapping device could make arrhythmia treatments more precise

NCT ID NCT02647749

Completed Diagnosis Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a non-invasive mapping system (Cardioinsight®) to help doctors treat heart rhythm disorders. It included 492 patients who needed ablation, pacemaker implantation, or risk assessment for sudden death. The goal was to see if the mapping system improves outcomes compared to standard methods without mapping.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cardioinsight® mapping system (device)
What this could lead to: If successful, this could make heart rhythm procedures more precise and reduce the need for repeat treatments.
What could go wrong: This is a completed care protocol, not a randomized trial, so results may be less definitive. The device may not work for all types of arrhythmias.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac rhythm disease ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC RHYTHM DISORDERS

Contacts and locations

Locations

CHU de Bordeaux

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.